Diploma PLC (LON:DPLM - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is GBX 5,365.
Several research firms have recently weighed in on DPLM. Jefferies Financial Group raised their price objective on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a "hold" rating in a research note on Thursday, September 11th. Royal Bank Of Canada raised Diploma to an "outperform" rating and lifted their target price for the stock from GBX 4,500 to GBX 6,000 in a research report on Friday. Shore Capital restated a "hold" rating and set a GBX 5,100 price target on shares of Diploma in a research note on Thursday, July 17th. Berenberg Bank lifted their target price on shares of Diploma from GBX 5,750 to GBX 6,350 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a GBX 4,440 target price on shares of Diploma in a report on Wednesday, August 6th.
View Our Latest Stock Report on Diploma
Diploma Trading Up 1.4%
LON:DPLM opened at GBX 5,327.15 on Friday. The business's 50-day simple moving average is GBX 5,384.87 and its 200 day simple moving average is GBX 4,730.93. Diploma has a one year low of GBX 3,532 and a one year high of GBX 5,625. The stock has a market cap of £7.14 billion, a price-to-earnings ratio of 4,285.72, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.